Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,772.67
-0.56%
DAX
26,299.74
-0.12%
CAC 40
8,650.56
-0.28%
STOXX 50
6,545.47
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

pharmaceuticals

  • Alibaba-backed LinkDoc mulls private $200m fundraiser after frozen US IPO

    September 9, 2021

    Chinese medical data firm LinkDoc Technology is reportedly looking to raise between $200m and $300m from a private fundraiser, weeks after it froze plans for a US float. LinkDoc, which is backed by Alibaba Health Information Technology, is also mulling a fresh initial public offering (IPO) in Hong Kong instead of across the pond, Bloomberg [...]

  • Compulsory jabs? Consultation on vaccinations for health staff begins

    September 9, 2021

    The government has launched a consultation today to make a decision on whether there should be compulsory jabs for frontline workers in health and care settings. The six-week long consultation could result in staff receiving mandatory Covid-19 and flu vaccines to protect their patients and people receiving their care, unless they are medically exempt. The [...]

  • Spire Healthcare returns to operating profit amid climbing Covid costs

    September 9, 2021

    Independent hospital group Spire Healthcare has returned to an operating profit in the past six months, after being hit by climbing Covid-19 costs. The group swung from a £189.8m operating loss last year, managing to secure £46.2m in the six months to 30 June, according to its interim results this morning. Revenue also jumped 38.9 [...]

  • French drugmaker Sanofi to spend $1.9bn to buy US biopharma firm Kadmon

    September 8, 2021

    French healthcare company Sanofi has announced its plans to acquire Kadmon, a US biopharmaceutical firm, for $1.9bn, according to reports. The news comes just one month after Sanofi announced its intention to buy another US biotech, Translate Bio, in a $3.2bn deal. The French drugmaker said it offered $9.50 per share in cash for Kadmon [...]

  • EU vs Astrazeneca: Vaccine legal battle over as UK pharma pledges jab deliveries

    September 3, 2021

    The legal stand-off between the European Union (EU) and FTSE-listed Covid-19 vaccine maker Astrazeneca appears to be over. Astrazeneca and the European Commission have reached a settlement on the delivery of 200m vaccine doses still to be delivered by the drug com[any, ending a row about shortages that had heightened reputational damage on Astra and weighed [...]

  • UK to share 4m vaccines with Australia

    September 3, 2021

    The UK and Australia have agreed to a partnership which will see some 4m vaccines shared with each other, as Britain’s double-jabbed population nears 80 per cent. Britain will be the first to ship over the large batch of Pzifer/BioNTech jabs, while Australia will return the same number before the end of the year. It [...]

  • Coronavirus: New Covid strain Mu lands in UK with 55 cases in England so far

    September 1, 2021

    A new Covid mutation called Mu has been detected in the UK, as 55 cases have been identified in England so far. The new strain, which first popped up in South America, has been designated a variant of interest by the World Health Organisation (WHO), according to various reports this morning. Mu, or B.1.621, was [...]

  • Metallic particles: Japan finds another contaminated Moderna vaccine

    September 1, 2021

    Japan reported a fresh contamination case involving Moderna’s Covid-19 vaccine, the fourth such incident in less than a week, threatening to slow the country’s sputtering inoculation campaign. Watch the full report.

  • Major setback for Johnson & Johnson as potential HIV vaccine fails to deliver

    August 31, 2021

    A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the pharmaceutical company has said. J&J plans to end the study, which involved young women in sub-Saharan Africa. But researchers will continue a separate, late-stage trial involving a different composition of the vaccine in [...]

  • New Zealand reports first Covid vaccine death: Woman dies after Pfizer jab

    August 30, 2021

    A health board that monitors vaccine safety said today that a woman had died from myocarditis after being given the Pfizer jab. The case marks New Zealand’s first reported coronavirus vaccine death. The board said the woman probably developed the condition because of the vaccine, although she had other medical issues which may have contributed. [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Page 20
  • Next

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Revolut takes flight with launch of new airport lounges

  • It’s not just Jason Arday, most of sociology is a scam

  • IT consultant ordered to pay £50,000 after being accused of stealing Soho House members’ personal details

  • As it happened: FTSE 100 falls as Iran and US clash over Strait of Hormuz; Oil stockpiles ‘rapidly depleting’

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook